Lenalidomide abrogates the survival effect of bone marrow stromal cells in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Lenalidomide abrogates the survival effect of bone marrow stromal cells in chronic lymphocytic leukemia

Published:2021-05-20 Issue:4 Volume:39 Page:513-520
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Kriston Csilla¹,Hernádfői Márk¹,Plander Márk²,Márk Ágnes¹,Takács Ferenc¹,Czeti Ágnes¹,Szalóki Gábor¹,Szabó Orsolya¹,Matolcsy András¹,Barna Gábor¹^ORCID

Affiliation:

1. Department of Pathology and Experimental Cancer Research Semmelweis University Budapest Hungary

2. Department of Hematology Markusovszky University Teaching Hospital Szombathely Hungary

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2888

Reference37 articles.

1. The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies

2. EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes

3. Resistance to ABT‐199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors;Thijssen R;Haematologica,2015

4. Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib

5. Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage-Based Therapeutic Strategies in Hematologic Malignancies;Cancers;2023-07-22

2. Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies;Frontiers in Oncology;2022-07-07

3. The Role of Tumor-Associated Macrophages in Hematologic Malignancies;Cancers;2021-07-18